ECASS 3 supports use of tPA up to 4.5 hours after stroke
28 October 2009
| by Amy Corderoy
Further analyses of data from the third European Cooperative Acute Stroke Study support the use of recombinant tissue plasminogen activator (tPA) to treat stroke up to 4.5 hours after symptom onset....
Want to read complete article? Please Sign in or Register.